{
    "root": "303cce0e-5261-9ffd-e063-6294a90ae784",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CARBAMAZEPINE",
    "value": "20250313",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STARCH, PREGELATINIZED CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CARBAMAZEPINE",
            "code": "33CM23913M"
        }
    ],
    "indications": null,
    "contraindications": null,
    "warningsAndPrecautions": "carbamazepine tablets , usp , 200 mg available following form : pink colored , capsule shaped , biconvex tablets '268 ' debossed one side scored side . ndc : 70518-2456-00 packaging : 30 1 blister pack store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect light moisture.dispense tight , light-resistant container defined usp . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "carbamazepine used patients history previous bone marrow depression , hypersensitivity , known sensitivity tricyclic compounds , amitriptyline , desipramine , imipramine , protriptyline , nortriptyline , etc . likewise , theoretical grounds monoamine oxidase ( mao ) inhibitors recommended . carbamazepine , mao inhibitors dis continued minimum 14 days , longer situation permits . coadministration carbamazepine nefazodone may result insufficient plasma concentrations nefazodone active metabolite achieve therapeutic effect . coadministration carbamazepine nefazodone contraindicated .",
    "warningsAndPrecautions_original": "Carbamazepine Tablets, USP, 200 mg are available in the following form: pink colored, capsule shaped, biconvex tablets with '268' debossed on one side and scored on the other side.\n                  \n                  NDC: 70518-2456-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\u00a0Protect from light and moisture.Dispense in a tight, light-resistant container as defined in the USP.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Carbamazepine should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug, or known sensitivity to any of the tricyclic compounds, such as amitriptyline, desipramine, imipramine, protriptyline, nortriptyline, etc. Likewise, on theoretical grounds its use with monoamine oxidase (MAO) inhibitors is not recommended. Before administration of carbamazepine, MAO inhibitors should be dis\u00a0continued for a minimum of 14 days, or longer if the clinical situation permits.\n                  Coadministration of carbamazepine and nefazodone may result in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect.\u00a0 Coadministration of carbamazepine with nefazodone is contraindicated."
}